Stemcentrx's Acquisition

Stemcentrx was acquired by AbbVie on April 28, 2016.

Stemcentrx is developing novel cancer therapies and diagnostics. Stemcentrx is looking to treat cancers by killing cancer stem cells, or cells thought to initiate tumors. These cells are believed to r…

Articles about Stemcentrx's Acquisition: